Correction to: MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming

Yang Liu^{1

2}, Li-Li Lu¹, Duo Wen^{1

3}, Dong-Li Liu^{1

4}, Li-Li Dong¹, Dong-Mei Gao¹, Xin-Yu Bian¹, Jian Zhou^{1

5}, Jia Fan^{6

7}, Wei-Zhong Wu⁸

Affiliations

¹ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
² Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
³ Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
⁴ Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China.
⁵ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
⁶ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
⁷ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
⁸ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. wu.weizhong@zs-hospital.sh.cn.

Published Erratum

Yang Liu et al. J Hematol Oncol. 2020.

. 2020 May 4;13(1):44.

doi: 10.1186/s13045-020-00875-5.

Yang Liu^{1

2}, Li-Li Lu¹, Duo Wen^{1

3}, Dong-Li Liu^{1

4}, Li-Li Dong¹, Dong-Mei Gao¹, Xin-Yu Bian¹, Jian Zhou^{1

5}, Jia Fan^{6

7}, Wei-Zhong Wu⁸

¹ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
² Department of Oral Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
³ Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
⁴ Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, 200080, China.
⁵ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
⁶ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
⁷ Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. fan.jia@zs-hospital.sh.cn.
⁸ Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, 180 Fenglin Road, Shanghai, 200032, China. wu.weizhong@zs-hospital.sh.cn.

Abstract

An amendment to this paper has been published and can be accessed via the original article.

MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming.
Liu Y, Lu LL, Wen D, Liu DL, Dong LL, Gao DM, Bian XY, Zhou J, Fan J, Wu WZ. Liu Y, et al. J Hematol Oncol. 2020 Feb 7;13(1):12. doi: 10.1186/s13045-019-0841-3. J Hematol Oncol. 2020. PMID: 32033570 Free PMC article.

1. Liu Y, et al. MiR-612 regulates invadopodia of hepatocellular carcinoma by HADHA-mediated lipid reprogramming. J Hematol Oncol. 2020;13:12. doi: 10.1186/s13045-019-0841-3. - DOI - PMC - PubMed